Trade Shows and Conferences

Upcoming Events: 

Outsourcing in Clinical Trials New England

September 6-7, 2017 - Boston, MA
Booth # 71

European Society for Medical Oncology (ESMO)

September 8-12, 2017 - Madrid, Spain
Booth # 27, Technology Hall

Past Events:

American Society of Clinical Oncology (ASCO)

June 2-5, 2017 - Chicago, IL
Booth # 18152

Outsourcing in Clinical Trials East Coast

May 23-24, 2017 - King of Prussia, PA
Booth # 62

Outsourcing in Clinical Trials West Coast

February 22-23, 2017 - Burlingame, CA
Booth # 16

BIO-Europe 22nd Annual Conference

November 7-9, 2016 - Cologne, Germany
Booth # 93

World Vaccine Congress 2016-Europe

October 10-12, 2016 – Barcelona, Spain

European Society for Medical Oncology (ESMO) 2016

October 7-11, 2016 – Copenhagen, Denmark

Options IX for the Control of Influenza

August 24-28, 2016 – Chicago, IL
Booth # 520

Outsourcing in Clinical Trials New England

September 7-8, 2016 – Boston, MA
Booth # 15

American Society of Clinical Oncology (ASCO)

June 3-7, 2016 – Chicago, IL
Booth #6129

World Vaccine Congress 2016

March 29-31, 2016 – Washington, DC
Booth #37

Orphan Drugs and Rare Diseases Global Congress 2016 Europe

March 14-16, 2016 – London, UK


March 1-2, 2016 – Cardiff, Wales

SCOPE Summit for Clinical Operations Executives

February 23-25, 2016 – Miami, FL

DPharm Europe

February 9-10, 2016 – London, UK

Outsourcing in Clinical Trials West

February 10-11, 2016 – San Mateo, CA
Booth #53

Phacilitate Washington BioLeaders Forum

January 25-27, 2016 – Washington, DC

Policy Conference, Cancer Care

January 26, 2016 – Wales


Articles & Interviews

Stephen Trevisan interview with CEO of PharmaVentures

Pivotal H7N9 Research Conducted with Accelovance Highlighted in Science Translational Medicine Manuscript

Stephen Trevisan interview on Executive Leaders Radio

Accelovance Participates in Pharmaceutical Outsourcing's Clinical Trials Roundtable"
or download as PDF

Press Releases

Accelovance Continues Growth With Key US Sales Hires

Accelovance Launches Global Initiative To Advance Promising Oncology Therapies

Accelovance Positioned for Continued Growth with New Sales and Marketing Executives

Panacea Pharmaceuticals and Accelovance Initiate Ph.1 Prostate Cancer Vaccine Study

Accelovance Investment Further Enhances Early Phase Oncology Services

Accelovance, Inc. Continues European Expansion with Acquisition of THERAMetrics AG’s CRO Services

Accelovance Selected to Advance Immunicum’s Oncology Immunotherapy Pipeline

Accelovance Prepared to Meet Emerging Needs for Zika Virus Research

Accelovance, Inc. Continues Geographic and Service Expansion with Acquisition of Clinquest, Inc. & BV

Accelovance, Inc. and FHI 360 Enhance Service Offering Through International Strategic Alliance

Accelovance and ERT Partner to Implement Cloud Based Data and Analytic Solution for Clinical Trial Clients

Accelovance Continues Oncology Leadership Growth with Addition of Former Global VP, Oncology from Wyeth/Pfizer and Bayer

Midwest Melanoma Partnership and Accelovance, Inc. Enhance Melanoma Research Offering Through Strategic Alliance

Accelovance, Inc. to Expand Global Workforce with
Grant from Welsh Government

Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial

Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards “Best Contract Research Organization”

Panacea Pharmaceuticals Engages Accelovance For Clinical Development Of Its Novel Nanoparticle-Based Therapeutic Cancer Vaccine

Accelovance Expands Capabilities in Europe with Acquisition of Altair Clinical, Ltd.

Accelovance Nominated for TWO 2014 Vaccine Industry Excellence (ViE) Awards - "Best Contract Research Organization" & "Best Clinical Trial Network and Site"

Accelovance Continues Expansion with Opening of Research Triangle Park, North Carolina Office